The mixture of sodium alginate and konjac is expected to become a new food ingredient in EU.

　　According to the latest knowledge of sodium alginate manufacturers on March 30, 2017, American nutritional food suppliers have previously applied for new food ingredients in the European Union for the mixed patented ingredients of konjac, sodium alginate and xanthan gum for weight loss. At present, the company sells this mixed ingredient (PGX) by its effects on cholesterol, blood sugar and insulin, appetite and weight loss. Will soon be made into a mixture of sodium alginate and konjac, a new food and a new ingredient of EU.
　

　　The British Food Standards Agency (FSA) objected to the initial assessment by the Israeli Food Safety Agency (FSAI), while the European Food Safety Agency (EFSA) made a new assessment of this application at the request of the European Commission.

　　Several questions raised by FSA include the possible laxative effect of containing 13.5g fiber per 15g of this mixed ingredient, and clarifying the market applications such as dairy desserts, puddings and biscuits. Because some consumer groups of these products may be children, it is necessary to warn of the danger of suffocation.

　　Since 2003, the European Union has explicitly banned the use of konjac glucomannan jelly candy because it is related to suffocation death. The company said that delaying the viscosity of PGX can prevent suffocation from the form of supplements.

　　The FDA said that according to its intended use conditions, the company failed to provide sufficient information to prove the safety of this polysaccharide complex, so the GRAS authentication of the company's application was also delayed in the United States in 2011.

　　In the European Union, glucomannan extracted from Amorphophallus konjac can carry two health claims approved by EFSA, and this nutrient is described in the context of an energy-restricted diet that helps to lose weight and maintain normal blood cholesterol levels.